These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26578817)

  • 1. Biophysical characterization of laforin-carbohydrate interaction.
    Dias DM; Furtado J; Wasielewski E; Cruz R; Costello B; Cole L; Faria TQ; Baaske P; Brito RM; Ciulli A; Simões I; Macedo-Ribeiro S; Faro C; Geraldes CF; Castanheira P
    Biochem J; 2016 Feb; 473(3):335-45. PubMed ID: 26578817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression, purification and characterization of soluble red rooster laforin as a fusion protein in Escherichia coli.
    Brewer MK; Husodo S; Dukhande VV; Johnson MB; Gentry MS
    BMC Biochem; 2014 Apr; 15():8. PubMed ID: 24690255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired malin expression and interaction with partner proteins in Lafora disease.
    Skurat AV; Segvich DM; Contreras CJ; Hu YC; Hurley TD; DePaoli-Roach AA; Roach PJ
    J Biol Chem; 2024 May; 300(5):107271. PubMed ID: 38588813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation.
    Fernández-Sánchez ME; Criado-García O; Heath KE; García-Fojeda B; Medraño-Fernández I; Gomez-Garre P; Sanz P; Serratosa JM; Rodríguez de Córdoba S
    Hum Mol Genet; 2003 Dec; 12(23):3161-71. PubMed ID: 14532330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The unique evolution of the carbohydrate-binding module CBM20 in laforin.
    Kuchtová A; Gentry MS; Janeček Š
    FEBS Lett; 2018 Feb; 592(4):586-598. PubMed ID: 29389008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the structural insights on human laforin mutation K87A in Lafora disease--a molecular dynamics study.
    Srikumar PS; Rohini K
    Appl Biochem Biotechnol; 2013 Oct; 171(4):874-82. PubMed ID: 23904258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural mechanism of laforin function in glycogen dephosphorylation and lafora disease.
    Raththagala M; Brewer MK; Parker MW; Sherwood AR; Wong BK; Hsu S; Bridges TM; Paasch BC; Hellman LM; Husodo S; Meekins DA; Taylor AO; Turner BD; Auger KD; Dukhande VV; Chakravarthy S; Sanz P; Woods VL; Li S; Vander Kooi CW; Gentry MS
    Mol Cell; 2015 Jan; 57(2):261-72. PubMed ID: 25544560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin.
    DePaoli-Roach AA; Tagliabracci VS; Segvich DM; Meyer CM; Irimia JM; Roach PJ
    J Biol Chem; 2010 Aug; 285(33):25372-81. PubMed ID: 20538597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laforin, a dual specificity phosphatase involved in Lafora disease, is present mainly as monomeric form with full phosphatase activity.
    Dukhande VV; Rogers DM; Romá-Mateo C; Donderis J; Marina A; Taylor AO; Sanz P; Gentry MS
    PLoS One; 2011; 6(8):e24040. PubMed ID: 21887368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy.
    Mitra S; Chen B; Wang P; Chown EE; Dear M; Guisso DR; Mariam U; Wu J; Gumusgoz E; Minassian BA
    Dis Model Mech; 2023 Jan; 16(1):. PubMed ID: 36511140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the Biological Activity of the Glucan Phosphatase Laforin.
    Romá-Mateo C; Raththagala M; Gentry MS; Sanz P
    Methods Mol Biol; 2016; 1447():107-19. PubMed ID: 27514803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal metabolism of glycogen phosphate as a cause for Lafora disease.
    Tagliabracci VS; Girard JM; Segvich D; Meyer C; Turnbull J; Zhao X; Minassian BA; Depaoli-Roach AA; Roach PJ
    J Biol Chem; 2008 Dec; 283(49):33816-25. PubMed ID: 18852261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and characterization of a laforin nanobody inhibitor.
    Simmons ZR; Sharma S; Wayne J; Li S; Vander Kooi CW; Gentry MS
    Clin Biochem; 2021 Jul; 93():80-89. PubMed ID: 33831386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased laforin and laforin binding to glycogen underlie Lafora body formation in malin-deficient Lafora disease.
    Tiberia E; Turnbull J; Wang T; Ruggieri A; Zhao XC; Pencea N; Israelian J; Wang Y; Ackerley CA; Wang P; Liu Y; Minassian BA
    J Biol Chem; 2012 Jul; 287(30):25650-9. PubMed ID: 22669944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimeric quaternary structure of human laforin.
    Sankhala RS; Koksal AC; Ho L; Nitschke F; Minassian BA; Cingolani G
    J Biol Chem; 2015 Feb; 290(8):4552-4559. PubMed ID: 25538239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo.
    Tagliabracci VS; Turnbull J; Wang W; Girard JM; Zhao X; Skurat AV; Delgado-Escueta AV; Minassian BA; Depaoli-Roach AA; Roach PJ
    Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19262-6. PubMed ID: 18040046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laforin in autophagy: a possible link between carbohydrate and protein in Lafora disease?
    Puri R; Ganesh S
    Autophagy; 2010 Nov; 6(8):1229-31. PubMed ID: 20818153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laforin, a dual-specificity phosphatase involved in Lafora disease, is phosphorylated at Ser25 by AMP-activated protein kinase.
    Romá-Mateo C; Solaz-Fuster Mdel C; Gimeno-Alcañiz JV; Dukhande VV; Donderis J; Worby CA; Marina A; Criado O; Koller A; Rodriguez De Cordoba S; Gentry MS; Sanz P
    Biochem J; 2011 Oct; 439(2):265-75. PubMed ID: 21728993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway.
    Solaz-Fuster MC; Gimeno-Alcañiz JV; Ros S; Fernandez-Sanchez ME; Garcia-Fojeda B; Criado Garcia O; Vilchez D; Dominguez J; Garcia-Rocha M; Sanchez-Piris M; Aguado C; Knecht E; Serratosa J; Guinovart JJ; Sanz P; Rodriguez de Córdoba S
    Hum Mol Genet; 2008 Mar; 17(5):667-78. PubMed ID: 18029386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the autophagic PI3KC3 complex by laforin/malin E3-ubiquitin ligase, two proteins involved in Lafora disease.
    Sanchez-Martin P; Lahuerta M; Viana R; Knecht E; Sanz P
    Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118613. PubMed ID: 31758957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.